Copenhagen, Denmark

Orphazyme A/s

Calculating rank
USPTO Granted Patents = 8


Forward Citations = 13

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Thomas Kirkegaard Jensen (8 out of 14 patents)

silverMedal Anders Mørkeberg Hinsby (4 out of 5 patents)

bronzeMedal Marja Helena Jaattela (3 out of 8 patents)

4.  Gert Mads Bolwig (2 out of 2 patents)

5.  Carlos Roberto Camozzi (2 out of 3 patents)

6.  Catherine Kolster Fog-Tonnesen (1 out of 1 patent)

7.  Nikolaj Havnsøe Torp Petersen (1 out of 1 patent)

8.  Claus Bornæs (1 out of 1 patent)

9.  Elina Ikonen (1 out of 1 patent)

10.  Burcin Gungor (1 out of 1 patent)

11.  Cathrine Kolster Fog-TØNNESEN (0 patent)


8 patents:

Company Overview
Orphazyme A/S is a biopharmaceutical company dedicated to developing treatments for patients living with rare neurodegenerative diseases. The company's lead candidate, arimoclomol, is currently in clinical trials for several rare diseases. Orphazyme is focused on bringing innovative therapies to market to improve the lives of patients and their families.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#41 in Copenhagen

#328 in Denmark

Copenhagen, DK
Copenhagen, Denmark
Forward Citations = 13

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Orphazyme A/s. Retrieved from https://idiyas.com/company/orphazyme-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…